L'Oreal takes stakes in Chinese, N.American clinics to understand medical aesthetics market
Published by Global Banking & Finance Review®
Posted on February 7, 2025
1 min readLast updated: January 26, 2026

Published by Global Banking & Finance Review®
Posted on February 7, 2025
1 min readLast updated: January 26, 2026

L'Oreal invests in clinics in China and North America to explore the medical aesthetics market and plans to enter the nutricosmetics sector.
PARIS (Reuters) - L'Oreal has taken stakes in clinics in China and North America in order to observe and understand the medical aesthetics market, L'Oreal CEO Nicolas Hieronimus said in an earnings call on Friday.
The company had announced in August the acquisition of a 10% stake in Swiss skin care firm Galderma.
Hieronimus added that L'Oreal would be entering the nutricosmetics market with a new product and said more would be coming.
(Reporting by Dominique Patton; Editing by Makini Brice and David Evans)
The article discusses L'Oreal's investment in clinics to understand the medical aesthetics market and its entry into nutricosmetics.
L'Oreal is investing to observe and understand the medical aesthetics market in China and North America.
Nutricosmetics refers to products that combine nutrition and cosmetics, aiming to improve beauty from within.
Explore more articles in the Finance category
